Purchase Summary

In order to access content on the FENIX Marketplace, you must have an account. You will also have access to FENIX Free updates.

The price for access is $599.00.

Account Information Already have an account? Log in here

Username

Password

Confirm Password

Work E-mail Address

Confirm E-mail Address

Occupation

Other

Full Name LEAVE THIS BLANK

Payment Information We accept all major credit cards

Card Number

Expiration Date

CVC

I want to receive updates from fenix.group.

By selecting this, I agree to receive emails from fenix.group.

Processing...

You will be redirected to view the full article after purchasing. You will receive your account and payment information in a confirmation email, and can be viewed at any time in your Account.

RETURN TO HOME

$599

Bolus Insulin

August 05, 2020

David Kendall to Leave MannKind; MannKind Q2 '20 Earnings Update

Here is a brief preview of this blast: MannKind hosted its Q2 '20 earnings call (press release) and provided updates to its business, particularly around how the company is continuing to cope with the COVID-19 pandemic. Importantly, MannKind disclosed the company's CMO, David Kendall, will be leaving the company. Below, FENIX provides highlights and insights from the call.